|
|||||
|
|
Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized,Controlled, Multicenter,Phase IV Trial |
|
| Authors: | Ono Koh Wada Hiromichi Satoh-Asahara Noriko Inoue Hitoki Uehara Keita Funada Junichi Ogo Atsushi Horie Takahiro Fujita Masatoshi Shimatsu Akira Hasegawa Koji |
| Affiliation: | 1.Clinical Research Institute, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, 612-8555, Japan ;2.Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan ;3.Department of Cardiology, National Hospital Organization Hokkaido Cancer Center, 2-3-54, Kikusuishijyo, Shiraishi-ku, Sapporo, Hokkaido, 003-0804, Japan ;4.Department of Gastroenterology, National Hospital Organization Tochigi Medical Center, 1-10-37, Nakatomatsuri, Utsunomiya, Tochigi, 3208580, Japan ;5.Department of Cardiology, National Hospital Organization Ehime Medical Center, 366 Yokogawara, Toon, Ehime, 791-0281, Japan ;6.Department of Metabolism and Endocrinology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan ;7.Department of Cardiovascular Medicine, Uji Hospital, Uji, Kyoto, Japan ; |
| Abstract: | American Journal of Cardiovascular Drugs - Metformin is the most widely used oral antihyperglycemic agent for patients with type 2 diabetes mellitus (T2DM). Despite the possible benefits of... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |